Kodiak Sciences Inc (KOD)
3.29
-0.45
(-12.03%)
USD |
NASDAQ |
May 17, 16:00
3.29
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Cash from Operations (Quarterly): -39.60M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -39.60M |
| December 31, 2023 | -32.24M |
| September 30, 2023 | -32.76M |
| June 30, 2023 | -41.96M |
| March 31, 2023 | -47.22M |
| December 31, 2022 | -55.08M |
| September 30, 2022 | -53.09M |
| June 30, 2022 | -55.14M |
| March 31, 2022 | -43.16M |
| December 31, 2021 | -59.04M |
| September 30, 2021 | -51.95M |
| June 30, 2021 | -36.66M |
| March 31, 2021 | -34.62M |
| Date | Value |
|---|---|
| December 31, 2020 | -27.02M |
| September 30, 2020 | -24.57M |
| June 30, 2020 | -13.90M |
| March 31, 2020 | -17.93M |
| December 31, 2019 | -11.29M |
| September 30, 2019 | -7.696M |
| June 30, 2019 | -12.95M |
| March 31, 2019 | -7.207M |
| December 31, 2018 | -8.34M |
| September 30, 2018 | -4.984M |
| June 30, 2018 | -4.448M |
| March 31, 2018 | -11.26M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-59.04M
Minimum
Dec 2021
-7.696M
Maximum
Sep 2019
-34.89M
Average
-35.64M
Median
Cash from Operations (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -6.202M |
| Regeneron Pharmaceuticals Inc | 1.512B |
| Ligand Pharmaceuticals Inc | 18.73M |
| iBio Inc | -4.706M |
| Dare Bioscience Inc | -6.813M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.166M |
| Cash from Financing (Quarterly) | 0.038M |
| Free Cash Flow | -175.76M |
| Free Cash Flow Per Share (Quarterly) | -0.7546 |
| Free Cash Flow Yield | -101.5% |